-
-
-
-
-
-
-
Chemours (CC) PT Lowered to $18 at Truist as 'Demand Challenges Persist'
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Chemours (CC)
-
-
-
-
-
-
-
Chemours (CC) PT Lowered to $20 at Truist Securities
-
-
-
-
-
-
-
The Chemours Company Reports Fourth Quarter and Full Year 2024 Results
-
-
-
-
-
-
-
Chemours (CC) PT Raised to $32 at BMO Capital
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Chemours
-
-
-
-
-
-
-
The Chemours Company Reports First Quarter 2024 Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

